Alkermes Plc ALKS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
24.65UNCH (UNCH)
Volume
199,906
Close
24.65quote price arrow up+0.39 (+1.61%)
Volume
1,536,842
52 week range
22.01 - 33.71
Loading...
  • Open24.26
  • Day High24.81
  • Day Low24.16
  • Prev Close24.26
  • 52 Week High33.71
  • 52 Week High Date06/26/23
  • 52 Week Low22.01
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap4.17B
  • Shares Out169.18M
  • 10 Day Average Volume1.97M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change-11.14

KEY STATS

  • Open24.26
  • Day High24.81
  • Day Low24.16
  • Prev Close24.26
  • 52 Week High33.71
  • 52 Week High Date06/26/23
  • 52 Week Low22.01
  • 52 Week Low Date10/25/23
  • Market Cap4.17B
  • Shares Out169.18M
  • 10 Day Average Volume1.97M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change-11.14

RATIOS/PROFITABILITY

  • EPS (TTM)3.02
  • P/E (TTM)8.16
  • Fwd P/E (NTM)9.08
  • EBITDA (TTM)495.049M
  • ROE (TTM)46.22%
  • Revenue (TTM)1.663B
  • Gross Margin (TTM)84.79%
  • Net Margin (TTM)31.21%
  • Debt To Equity (MRQ)24.17%

EVENTS

  • Earnings Date07/22/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alkermes Plc

 

Profile

MORE
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development...
Richard Pops
Chairman of the Board, Chief Executive Officer
Blair Jackson
Chief Operating Officer, Executive Vice President
Iain Brown
Chief Financial Officer, Senior Vice President
David Gaffin
Executive Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary
Craig Hopkinson M.D.
Executive Vice President, Research and Development and Chief Medical Officer
Address
Connaught HSE, 1 Burlington Road
Dublin
00000
Ireland